MicroMed Technology, Inc.
New children's heart pump may save lives
Published in Cardiovascular Device Liability Week, April 4th, 2004
A scaled-down model of the original pump designed by renowned heart surgeon Dr. Michael DeBakey and NASA engineers could be implanted in a child within weeks, according to the producer of the device. The U.S. Food and Drug Administration recently signed off on plans to use it, said Dallas Anderson, chief executive and president of MicroMed Technology, Inc.
The pump is for children ages 5-16, previously deemed too small for an implant.
"We decided we needed to make a pump for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Shiga University of Medical Science
AT1 receptors linked to insulin resistance-induced vascular dysfunction - Seattle Institute for Cardiac Research
Implanted defibrillator reduces heart failure deaths - San Raffaele H. Science Institute
Chromogranin A offers vessels protection against TNF-alpha-induced leakage - Ruhr University of Bochum
AT2 -receptor antagonists block Ang II effects on atrial noradrenaline release - Rubicon Medical Corp.
Martin Leon to lead studies of Rubicon Filter - Royal Netherlands Academy of Arts & Sciences
MCIP1 overexpression preserves post-infarction cardiac function - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
